File | |
Authors |
Harada, Tomoya
Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University
Researchers DB
Kato, Ryohei
Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University
Sueda, Yuriko
Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University
Funaki, Yoshihiro
Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University
Researchers DB
Takata, Miki
Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University
Researchers DB
Okazaki, Ryota
Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University
Researchers DB
Hasegawa, Yasuyuki
Division of Rheumatology, Tottori Prefectural Central Hospital
Yamasaki, Akira
Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University
Researchers DB
KAKEN
|
Keywords | Dose reduction
efficacy
pneumocystis pneumonia
prophylaxis
sulfamethoxazole-trimethoprim
|
Publisher | Taylor & Francis
|
Content Type |
Journal Article
|
ISSN | 14397595
|
EISSN | 14397609
|
Journal Title | MODERN RHEUMATOLOGY
|
Current Journal Title |
MODERN RHEUMATOLOGY
|
Volume | 31
|
Issue | 3
|
Start Page | 629
|
End Page | 635
|
Published Date | 2020-09-08
|
Publisher-DOI | |
Text Version |
Author
|
Rights | © 2020 Japan College of Rheumatology. This is an Accepted Manuscript of an article published by Taylor & Francis in MODERN RHEUMATOLOGY on 09 Sep 2020, available online: https://www.tandfonline.com/doi/10.1080/14397595.2020.1812834
|
Citation | Harada Tomoya, Kato Ryohei, Sueda Yuriko, et al. The efficacy and safety of reduced-dose sulfamethoxazole-trimethoprim for chemoprophylaxis ofPneumocystispneumonia in patients with rheumatic diseases. MODERN RHEUMATOLOGY. 2020, 31(3), 629-635. doi:10.1080/14397595.2020.1812834
|
Department |
Faculty of Medicine/Graduate School of Medical Sciences/University Hospital
|
Language |
English
|
Web of Science Key ut | WOS:000567584200001
|